Skip to main content

Advertisement

Table 2 Summary of RA patients for whom analysis IL-17-positive CD4 T cells in the blood was conducted

From: Rheumatoid synovial fluid interleukin-17-producing CD4 T cells have abundant tumor necrosis factor-alpha co-expression, but little interleukin-22 and interleukin-23R expression

RA patients (n) 44
Age, years (median (IQR)) 56 (50 to 65.5)
Sex, female (n) 28
Disease duration, years (median (IQR)) 3.5 (1.0 to 5.5)
RF positive (n) 32
ACPA positive (n) 30
ESR, mm/hr (median (IQR)) 24 (10 to 40)
CRP, mg/ml (median (IQR)) 11 (<5 to 23)
DAS28 (ESR) (median (IQR)) 5.15 (4.01 to 6.17)
% IL17-positive CD4 T cells (median (IQR)) 1.08 (0.60 to 1.64)
% IL17-positive CD45RO CD4 T cells (median (IQR)) 1.10 (0.47 to 1.79)
  1. IQR, interquartile range.